Sodium bicarbonate and Hepatocellular injury - a phase IV clinical study of FDA data

Summary:

Hepatocellular injury is reported as a side effect among people who take Sodium bicarbonate (sodium bicarbonate), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Ondansetron, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Hepatocellular injury when taking Sodium bicarbonate. It is created by eHealthMe based on reports of 27,114 people who have side effects when taking Sodium bicarbonate from the FDA, and is updated regularly.

What is Sodium bicarbonate?

Sodium bicarbonate has active ingredients of sodium bicarbonate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 27,283 Sodium bicarbonate users. Check the latest studies of Sodium bicarbonate.

What is Hepatocellular injury?

Hepatocellular injury (liver injury) is found to be associated with 700 drugs and 952 conditions by eHealthMe. Check the latest studies of Hepatocellular injury.

On Jul, 03, 2026

27,114 people reported to have side effects when taking Sodium bicarbonate.
Among them, 46 people (0.17%) have Hepatocellular injury.

Could Sodium bicarbonate cause Hepatocellular injury?

Among these 46 people:

How long have people been on Sodium bicarbonate when they have Hepatocellular injury? *

What is the gender of people who have Hepatocellular injury when taking Sodium bicarbonate? *

female: 44.19 %
male: 55.81 %

What is the age of people who have Hepatocellular injury when taking Sodium bicarbonate? *

What are other drugs people take besides Sodium bicarbonate? *

What are other side effects people have besides Hepatocellular injury? *

Thrombocytopenia (decrease of platelets in blood): 11 people, 23.91%
Fever: 10 people, 21.74%
Acute Kidney Failure: 9 people, 19.57%
Diarrhea: 9 people, 19.57%
Oedema Peripheral (superficial swelling): 9 people, 19.57%
Rashes (redness): 8 people, 17.39%
Colitis (inflammation of colon): 8 people, 17.39%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 7 people, 15.22%
Swallowing Pain Or Burning: 7 people, 15.22%
Hypotension (abnormally low blood pressure): 7 people, 15.22%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 11 people, 23.91%
High Blood Pressure: 9 people, 19.57%
Gout (uric acid crystals building up in the body): 9 people, 19.57%
Anaemia (lack of blood): 7 people, 15.22%
Diabetes: 6 people, 13.04%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 6 people, 13.04%
Type 2 Diabetes: 6 people, 13.04%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 13.04%
Lung Cancer - Non-Small Cell (lung cancer): 5 people, 10.87%
Pain: 4 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Sodium bicarbonate and have Hepatocellular injury?

- Check whether Hepatocellular injury is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sodium bicarbonate:

Sodium bicarbonate (27,283 reports)

Browse all side effects of Sodium bicarbonate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatocellular injury:

Hepatocellular injury (700 drugs)

Browse all the conditions that are associated with Hepatocellular injury:

Hepatocellular injury (952 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sodium bicarbonate (the active ingredients of Sodium bicarbonate) and Sodium bicarbonate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.